Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Life-threatening hypothyroidism associated with administration of cyclosporine in a patient treated with reduced-intensity hematopoietic stem-cell transplantation for metastatic renal-cell carcinoma.
Imataki O, Kim SW, Kojima R, Hori A, Hamaki T, Sakiyama M, Murashige N, Satoh M, Kami M, Makimoto A, Takaue Y. Imataki O, et al. Transplantation. 2003 Mar 27;75(6):898-907. doi: 10.1097/01.TP.0000055048.16538.4E. Transplantation. 2003. PMID: 12660521 No abstract available.
Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
Nakai K, Mineishi S, Kami M, Saito T, Hori A, Kojima R, Imataki O, Hamaki T, Yoshihara S, Ohnishi M, Kim SW, Ando T, Fumitoh A, Kanda Y, Makimoto A, Tanosaki R, Kanai S, Heike Y, Ohnishi T, Kawano Y, Wakasugi H, Takaue Y. Nakai K, et al. Among authors: imataki o. Transplantation. 2003 Jun 27;75(12):2135-43. doi: 10.1097/01.TP.0000066453.32263.F7. Transplantation. 2003. PMID: 12829926
Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kojima R, Kami M, Kim SW, Murashige N, Kishi Y, Hori A, Imataki O, Hamaki T, Sakiyama M, Masuo S, Fujisawa Y, Makimoto A, Heike Y, Tanosaki R, Takaue Y. Kojima R, et al. Among authors: imataki o. Bone Marrow Transplant. 2003 Aug;32(4):439-42. doi: 10.1038/sj.bmt.1704146. Bone Marrow Transplant. 2003. PMID: 12900783
Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation.
Hori A, Kami M, Kim SW, Chizuka A, Kojima R, Imataki O, Sakiyama M, Hamaki T, Onishi Y, Usubuchi N, Kishi Y, Murashige N, Tajima K, Miyakoshi S, Heike Y, Masuo S, Taniguchi S, Takaue Y. Hori A, et al. Among authors: imataki o. Biol Blood Marrow Transplant. 2004 Jan;10(1):65-72. doi: 10.1016/j.bbmt.2003.09.006. Biol Blood Marrow Transplant. 2004. PMID: 14752781 Free article.
Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies.
Hamaki T, Kami M, Kim SW, Onishi Y, Kishi Y, Murashige N, Hori A, Kojima R, Sakiyama M, Imataki O, Heike Y, Tanosaki R, Masuo S, Miyakoshi S, Taniguchi S, Tobinai K, Takaue Y. Hamaki T, et al. Among authors: imataki o. Bone Marrow Transplant. 2004 May;33(9):891-900. doi: 10.1038/sj.bmt.1704477. Bone Marrow Transplant. 2004. PMID: 15048142 Clinical Trial.
A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in Japan.
Imataki O, Kami M, Kim SW, Gotoh M, Komaba S, Kasai M, Hashino S, Naito K, Masuda M, Anan K, Teshima H, Togitani K, Inoue T, Nishimura M, Adachi Y, Fukuhara T, Yamashita T, Uike N, Kobayashi Y, Hamaguchi M, Higuchi M, Kawakami K, Takaue Y. Imataki O, et al. Bone Marrow Transplant. 2004 Jun;33(12):1173-9. doi: 10.1038/sj.bmt.1704526. Bone Marrow Transplant. 2004. PMID: 15094754
Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0.
Sakiyama M, Kami M, Hori A, Imataki O, Hamaki T, Murashige N, Kobayashi K, Kishi Y, Kojima R, Kim SW, Kusumi E, Yuji K, Miyakoshi S, Mori S, Tanosaki R, Taniguchi S, Takaue Y; Tokyo SCT Consortium. Sakiyama M, et al. Among authors: imataki o. Bone Marrow Transplant. 2004 Nov;34(9):787-94. doi: 10.1038/sj.bmt.1704673. Bone Marrow Transplant. 2004. PMID: 15361909
167 results